Public Profile

CS Medica A/S

CS Medica A/S, headquartered in Denmark (DK), is a pioneering company in the medical device industry, specialising in innovative solutions for chronic pain management and respiratory care. Founded in 2015, CS Medica has rapidly established itself as a leader in the development of advanced medical technologies, focusing on non-invasive treatments that enhance patient quality of life. The company’s core offerings include cutting-edge devices for pain relief and respiratory support, distinguished by their user-friendly design and efficacy. With a commitment to research and development, CS Medica has achieved significant milestones, including numerous patents and certifications that underscore its dedication to safety and innovation. As a trusted name in the healthcare sector, CS Medica continues to expand its market presence, delivering unique solutions that meet the evolving needs of patients and healthcare professionals alike.

DitchCarbon Score

How does CS Medica A/S's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

CS Medica A/S's score of 23 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.

17%

Let us know if this data was useful to you

CS Medica A/S's reported carbon emissions

CS Medica A/S, headquartered in Denmark (DK), currently does not have available carbon emissions data for the most recent year, nor do they have specific reduction targets or commitments outlined in their climate initiatives. Without concrete emissions figures or defined climate pledges, it is challenging to assess their carbon footprint or sustainability efforts. However, the company may still be engaged in broader industry practices aimed at reducing environmental impact, although specific details are not provided.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. CS Medica A/S's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for CS Medica A/S is in DK, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

CS Medica A/S is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Annabis Medical s.r.o

CZ
Updated 4 months ago
DitchCarbon Score

Andalou Naturals Inc.

US
Chemicals nec
Updated 4 months ago
DitchCarbon Score

Sonoma Pharmaceuticals

US
Pharmaceutical Preparation Manufacturing
Updated 7 days ago

Unilever

GB
Food products nec
Updated about 2 hours ago

Charlotte's Web Holdings, Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 7 days ago

Procter And Gamble

US
Chemicals nec
Updated 7 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers